Tecnimede Group is dedicated to the improvement and preservation of human life and health through the development and commercialization of pharmaceutical products with a strong focus on quality and technological innovation.






Simvastatin 40 mg has launched in Morocco

Tecnimede Maroc launched in October 2005 Simvastatine 40 mg pack of 30 and 60 tablets. With this dosage form, doctors could better treat patients with high cardiovascular risks.




A new software for helping doctors

Tecnimede Maroc in collaboration with Professor Mohamed Alami, Cardiologist, developed a new software for helping doctors to evaluating and treating the cardio-vascular risk, based on Framigham Study, the JNC 7 and the ATP III. This software was pres




A new positive opinion by MRP

In 12th October 2005, Tecnimede Espaņa obtained the positive opinion of the MRP for granting the marketing authorization for Carvedilol 6.25 mg and 25 mg tablets. In this procedure Portugal is also the reference country.




New pack of Fluconazole 150 mg in Morocco

Tecnimede Maroc launched in September 2005 a new pack of 4 capsules of Fluconazole 150 mg. This presentation completes the already existing packs of 1, 2 and 4 capsules.




A new approval in Spain by MRP

In 30th May 2005, Tecnimede España obtained the marketing authorization for Simvastatin 40 mg tablets. With this new approval the company already has 5 authorized product in Spain, all of them by MRP having Portugal as reference country.




Tecnimede Maroc reinforce product range in cardiology

Tecnimede Maroc launched in May 2005 Simvastatine 20mg pack of 30 and 60 tablets. The launch of Simvastatine constitutes a decisive step in the reinforcement of Tecnimede Maroc in cardiology area.




Launch of Nimodipie intravenous solution form In Morocco

Tecnimede Morocco launched in April 2005 the intravenous solution form of Nimodipine 10mg/50ml IV. This presentation comes to complete the presentations of nimodipine already existing in Morocco, 30 mg pack of 30 and 60 tablets.